Literature DB >> 10868449

Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men.

Y Kuwahara1, S Kono, H Eguchi, H Hamada, K Shinchi, K Imanishi.   

Abstract

BACKGROUND: Whereas chronic atrophic gastritis is known to be an intermediate stage in gastric carcinogenesis, information is sparse about factors associated with this precancerous lesion except for Helicobacter pylori.
METHODS: In a cross-sectional study of 566 men aged 50-55 years in the Japan Self-Defense Forces, we examined the relation of H. pylori infection, smoking, alcohol use, and dietary factors to the prevalence of chronic atrophic gastritis as determined by serum pepsinogen I and pepsinogen II (I/II ratio < 3.0. and pepsinogen I < 70 ng/ml). Chronic atrophic gastritis was classified as severe when the pepsinogen I/II ratio was < 2.0, and as moderate otherwise.
RESULTS: The overall prevalence of chronic atrophic gastritis was 35.7% (202 of 566). The seropositivity of H. pylori was associated with a 10-fold increase in the risk of chronic atrophic gastritis, and the association was much stronger for moderate atrophic gastritis. Neither cigarette smoking nor alcohol consumption was related to the overall risk of chronic atrophic gastritis. Consumption of vegetables and fruits was each unrelated to chronic atrophic gastritis whether examined as a whole or separately for moderate and severe atrophic gastritis. Green tea was related to decreased risk of severe atrophic gastritis, although not statistically significant, whereas garlic consumption showed no protective association.
CONCLUSIONS: The findings corroborate that H. pylori infection has an important role in the development of chronic atrophic gastritis in middle-aged Japanese men. Green tea consumption may be protective against the advance of atrophic gastritis. Vegetables, fruits, or garlic had no protective effect against the development of atrophic gastritis in the study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868449     DOI: 10.1080/003655200750023723

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.

Authors:  Pei-Fang Ning; Hui-Jie Liu; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

2.  Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.

Authors:  Asahi Hishida; Keitaro Matsuo; Yasuyuki Goto; Nobuyuki Hamajima
Journal:  World J Gastrointest Oncol       Date:  2010-10-15

3.  Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.

Authors: 
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 4.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 5.  Different Pathophysiology of Gastritis in East and West? A Western Perspective.

Authors:  Hans-Peter Wirth; Manqiao Yang
Journal:  Inflamm Intest Dis       Date:  2016-05-14

6.  Lifestyle change influences on GERD in Japan: a study of participants in a health examination program.

Authors:  Tetsuya Murao; Kouichi Sakurai; Syuuichi Mihara; Toru Marubayashi; Yoshitaka Murakami; Yutaka Sasaki
Journal:  Dig Dis Sci       Date:  2011-04-13       Impact factor: 3.199

7.  Dietary Factors in Relation to Helicobacter pylori Infection.

Authors:  Seyyed Ali Mard; Hossein Khadem Haghighian; Vahid Sebghatulahi; Bijan Ahmadi
Journal:  Gastroenterol Res Pract       Date:  2014-12-02       Impact factor: 2.260

8.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.